Research supports the view that sentinel node biopsy is the standard of care in high-risk primary melanoma [3]

Journal of Clinical Oncology

Volumn 24, Issue 18, 2006, Pages 2965-2966

  Kretschmer, Lutz ^a   Hilgers, Reinhard ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMETRY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; DISEASE CONTROL; FALSE NEGATIVE RESULT; HIGH RISK PATIENT; HUMAN; LETTER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; MORBIDITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; LYMPHADENECTOMY; NOTE; PATHOLOGY; SKIN TUMOR;

HUMANS; LYMPH NODE EXCISION; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 33745528910     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.5854     Document Type: Letter

References (14)

1. Thomas JM: Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. J Clin Oncol 23:9443-9444, 2005
2. Pawlik TM, Ross MI, Thompson JF, et al: The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 23:4588-4590, 2005
3. Kretschmer L, Beckmann I, Thorns KM, et al: Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas. Eur J Cancer 41:531-538, 2005
4. Lee RJ, Gibbs JF, Proulx GM, et al: Nodal basin recurrence following lymph node dissection for melanoma: Implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 46:467-474, 2000
5. Veronesi U, Adamus J, Bandiera DC, et al: Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 297:627-630, 1977
6. Cascinelli N, Morabito A, Santinami M, et al: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial: WHO Melanoma Programme. Lancet 351:793-796, 1998
7. Balch CM, Soong SJ, Bartolucci AA, et al: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255-263, 1996
8. Morton DL, Thompson JF, Cochran AJ, et al: Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. J Clin Oncol 23:710S, 2005 (suppl; abstr 7500)
9. Kretschmer L, Hilgers R, Mohrle M, et al: Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 40:212-218, 2004
10. Morton DL, Hoon DS, Cochran AJ, et al: Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238:538-549, 2003
11. van Akkooi AC, de Wilt JH, Verhoef C, et al: High positive sentinel node identification rate by EORTC melanoma group protocol: Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 42:372-380, 2006
12. de Vries M, Vonkeman WG, van Ginkel RJ, et al: Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol 31:778-783, 2005
13. Kretschmer L, Peeters S, Beckmann, et al: Intraoperative detection of sentinel lymph nodes in cutaneous malignant melanoma: Blue dye alone versus blue dye plus gamma-detection. J Dtsch Dermatol Ges 3:615-622, 2005
14. Morton DL, Cochran AJ, Thompson JF, et al: Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242:302-311, 2005